October 1, 2016
Epineuron Technologies is a medical device company developing tomorrow’s gold standard of care for damaged or impaired nerves by developing a set of devices for intra- and post- operative use that supercharges neurons and the regenerative process, that will substantially shorten recovery times for patients and maximize sensory and motor function.
The current standard of treatment for peripheral nerve injuries (PNIs) is limited to a do-nothing-and-
see-approach or surgery. PNIs affect as many as 20 million people in the U.S. alone, largely comprised of
compressive neuropathies (carpal tunnel syndrome) and nerve trauma, and can have a major impact on a
person’s quality of life. Impaired or injured nerves can affect the ability to move and perform tasks as simple as
holding a pen and writing. They can also affect the ability to sense touch, temperature and pain, putting a person
at risk of more injury.
In that regard, Epineuron is developing electroceutical (electricity as a therapeutic agent) devices that supercharge
neurons and kick-start the regenerative process. Our devices can be used by medical professionals at the time
of injury or during surgery to deliver therapeutic electrical stimulation. Epineuron’s technology will substantially shorten
recovery times for patients and maximize sensory and motor function allowing patients to resume their lives